Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 24, 2022	Sep. 25, 2021
OPERATING ACTIVITIES
Net income	$ 337,612	$ 268,209
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	42,627	36,532
Non-cash interest charges	290	336
Provisions for losses on trade and other accounts receivable	8,346	3,884
Gains on sales/disposals of operating property	(1,290)	(1,259)
Deferred income taxes, net	(2,597)	4,948
Stock-based compensation	9,409	18,717
Changes in operating assets and liabilities:
Decrease (increase) in trade and other accounts receivable	26,170	(224,503)
Increase in other assets	(17,669)	(3,822)
Increase in accounts payable	39,924	167,880
(Decrease) increase in other liabilities	(23,932)	22,837
Increase (decrease) in insurance claims	17,491	(76,769)
NET CASH PROVIDED BY OPERATING ACTIVITIES	436,381	216,990
INVESTING ACTIVITIES
Sales and maturities of investments	27,568	25,521
Purchases of investments	(30,490)	(77,649)
Purchases of operating property	(21,096)	(18,561)
Proceeds from sales of operating property	2,669	2,047
Purchase of non-marketable securities	(4,999)
NET CASH USED BY INVESTING ACTIVITIES	(26,348)	(68,642)
FINANCING ACTIVITIES
(Decrease) increase in cash overdraft	(18,792)	14,210
Dividends paid	(104,893)	(102,463)
Payment for debt issue costs	(1,080)
Proceeds from exercises of stock options	56	134
Taxes paid in lieu of shares issued related to stock-based compensation plans	(10,427)	(2,342)
Purchases of common stock	(285,983)	(50,230)
Principal payments on finance lease obligations	(29,075)	(26,513)
Payment of deferred consideration		(168)
NET CASH USED BY FINANCING ACTIVITIES	(450,194)	(167,372)
Effect of exchange rate changes on cash and cash equivalents	(1,614)	234
Decrease in cash, cash equivalents and restricted cash	(41,775)	(18,790)
Cash, cash equivalents and restricted cash at beginning of period	219,571	249,354
Cash and cash equivalents at end of period	$ 177,796	$ 230,564